NPCE
Price:
$13.7216
Market Cap:
$467.82M
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded...[Read more]
Industry
Medical - Devices
IPO Date
2021-04-22
Stock Exchange
NASDAQ
Ticker
NPCE
According to NeuroPace, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -23.66. This represents a change of -3.26% compared to the average of -24.46 of the last 4 quarters.
The mean historical PE Ratio of NeuroPace, Inc. over the last ten years is -9.96. The current -23.66 PE Ratio has changed 23.66% with respect to the historical average. Over the past ten years (40 quarters), NPCE's PE Ratio was at its highest in in the December 2020 quarter at 891.43. The PE Ratio was at its lowest in in the December 2025 quarter at -47.25.
Average
-9.96
Median
-9.24
Minimum
-23.39
Maximum
-0.78
Discovering the peaks and valleys of NeuroPace, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 940.64%
Maximum Annual PE Ratio = -0.78
Minimum Annual Increase = -83.21%
Minimum Annual PE Ratio = -23.39
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -23.39 | 94.43% |
| 2024 | -12.03 | 48.22% |
| 2023 | -8.12 | 940.64% |
| 2022 | -0.78 | -83.21% |
| 2021 | -4.65 | -59.62% |
| 2020 | -11.50 | 24.42% |
The current PE Ratio of NeuroPace, Inc. (NPCE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-14.51
5-year avg
-9.79
10-year avg
-9.96
NeuroPace, Inc.’s PE Ratio is greater than Cerus Corporation (-61.88), less than RxSight, Inc. (-5.50), less than CVRx, Inc. (-2.70), less than 908 Devices Inc. (-8.67), less than BrainsWay Ltd. (68.51), less than Senseonics Holdings, Inc. (-2.42), less than Sight Sciences, Inc. (-7.59), less than Delcath Systems, Inc. (796.87), less than Genelux Corporation (-2.89), less than Aldeyra The (-3.48),
| Company | PE Ratio | Market cap |
|---|---|---|
| -61.88 | $451.42M | |
| -5.50 | $257.28M | |
| -2.70 | $144.78M | |
| -8.67 | $348.66M | |
| 68.51 | $591.93M | |
| -2.42 | $218.79M | |
| -7.59 | $292.73M | |
| 796.87 | $440.15M | |
| -2.89 | $114.12M | |
| -3.48 | $95.91M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroPace, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like NeuroPace, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is NeuroPace, Inc.'s PE Ratio?
How is the PE Ratio calculated for NeuroPace, Inc. (NPCE)?
What is the highest PE Ratio for NeuroPace, Inc. (NPCE)?
What is the 3-year average PE Ratio for NeuroPace, Inc. (NPCE)?
What is the 5-year average PE Ratio for NeuroPace, Inc. (NPCE)?
How does the current PE Ratio for NeuroPace, Inc. (NPCE) compare to its historical average?